0 782

Cited 5 times in

Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection.

DC Field Value Language
dc.contributor.author김경식-
dc.contributor.author김도영-
dc.contributor.author박영년-
dc.contributor.author안상훈-
dc.contributor.author이혜원-
dc.contributor.author최기홍-
dc.contributor.author최진섭-
dc.contributor.author한광협-
dc.date.accessioned2018-07-20T08:07:57Z-
dc.date.available2018-07-20T08:07:57Z-
dc.date.issued2017-
dc.identifier.issn0030-2414-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/160861-
dc.description.abstractBACKGROUND: The clinical features of hepatocellular carcinoma (HCC) differ in patients with and without cirrhosis. OBJECTIVE: We aimed to investigate the long-term outcomes of noncirrhotic HCC patients after curative resection. METHODS: We retrospectively examined 649 consecutive patients with HCC who underwent curative resection from 1996 to 2012; 387 (59.6%) were cirrhotic and 262 (40.4%) were noncirrhotic. RESULTS: The mean age was 54.7 years, and 511 (78.7%) of the study participants were men. The most common cause of HCC was hepatitis B virus (n = 419, 64.6%). Noncirrhotic tumors were larger and more advanced than cirrhotic tumors. However, the noncirrhotic group showed better disease-free survival (DFS) and overall survival (OS) after resection than the cirrhotic group (median 64.0 vs. 56.0 months for OS and 48.0 vs. 31.0 months for DFS, p < 0.05). The predictors for HCC recurrence were cirrhosis, tumor number, portal vein invasion, and major surgery. CONCLUSIONS: Noncirrhotic HCC showed better DFS and OS after resection than cirrhotic HCC, although noncirrhotic HCC presented more aggressively.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherKarger-
dc.relation.isPartOfONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHCarcinoma, Hepatocellular/mortality-
dc.subject.MESHCarcinoma, Hepatocellular/pathology-
dc.subject.MESHCarcinoma, Hepatocellular/surgery-
dc.subject.MESHDisease-Free Survival-
dc.subject.MESHFemale-
dc.subject.MESHHepatectomy/mortality-
dc.subject.MESHHepatectomy/statistics & numerical data-
dc.subject.MESHHepatitis B/complications-
dc.subject.MESHHepatitis B/mortality-
dc.subject.MESHHepatitis B/pathology-
dc.subject.MESHHepatitis C/complications-
dc.subject.MESHHepatitis C/mortality-
dc.subject.MESHHepatitis C/pathology-
dc.subject.MESHHumans-
dc.subject.MESHLiver Cirrhosis/mortality-
dc.subject.MESHLiver Cirrhosis/pathology-
dc.subject.MESHLiver Neoplasms/mortality-
dc.subject.MESHLiver Neoplasms/pathology-
dc.subject.MESHLiver Neoplasms/surgery-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHNeoplasm Recurrence, Local/mortality-
dc.subject.MESHPrognosis-
dc.subject.MESHRepublic of Korea/epidemiology-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHSurvival Analysis-
dc.subject.MESHTreatment Outcome-
dc.titleLess Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection.-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Surgery-
dc.contributor.googleauthorLee H.W.-
dc.contributor.googleauthorChoi G.H.-
dc.contributor.googleauthorKim D.Y.-
dc.contributor.googleauthorPark Y.N.-
dc.contributor.googleauthorKim K.S.-
dc.contributor.googleauthorChoi J.S.-
dc.contributor.googleauthorAhn S.H.-
dc.contributor.googleauthorHan K.-H-
dc.identifier.doi10.1159/000477173-
dc.contributor.localIdA00299-
dc.contributor.localIdA00385-
dc.contributor.localIdA01563-
dc.contributor.localIdA02226-
dc.contributor.localIdA03318-
dc.contributor.localIdA04046-
dc.contributor.localIdA04199-
dc.contributor.localIdA04268-
dc.relation.journalcodeJ02416-
dc.identifier.eissn1423-0232-
dc.identifier.pmid28571030-
dc.identifier.urlhttps://www.karger.com/Article/FullText/477173-
dc.subject.keywordCirrhosis-
dc.subject.keywordHepatocellular carcinoma-
dc.subject.keywordSurgical resection-
dc.contributor.alternativeNameKim, Kyung Sik-
dc.contributor.alternativeNameKim, Do Young-
dc.contributor.alternativeNamePark, Young Nyun-
dc.contributor.alternativeNameAhn, Sang Hoon-
dc.contributor.alternativeNameLee, Hye Won-
dc.contributor.alternativeNameChoi, Gi Hong-
dc.contributor.alternativeNameChoi, Jin Sub-
dc.contributor.alternativeNameHan, Kwang Hyup-
dc.contributor.affiliatedAuthorKim, Kyung Sik-
dc.contributor.affiliatedAuthorKim, Do Young-
dc.contributor.affiliatedAuthorPark, Young Nyun-
dc.contributor.affiliatedAuthorAhn, Sang Hoon-
dc.contributor.affiliatedAuthorLee, Hye Won-
dc.contributor.affiliatedAuthorChoi, Gi Hong-
dc.contributor.affiliatedAuthorChoi, Jin Sub-
dc.contributor.affiliatedAuthorHan, Kwang Hyup-
dc.citation.volume93-
dc.citation.number4-
dc.citation.startPage224-
dc.citation.endPage232-
dc.identifier.bibliographicCitationONCOLOGY, Vol.93(4) : 224-232, 2017-
dc.identifier.rimsid60745-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.